Clinical Trials | June 18, 2026
Suven reports positive Phase 2b results for Ropanicant in major depressive disorder
Suven has already begun planning a global Phase 3 registrational program for MDD based on the results
Suven has already begun planning a global Phase 3 registrational program for MDD based on the results
The newly approved treatment, SKINVIVE by JUVÉDERM, is now the first and only hyaluronic acid injectable cleared specifically for improving neck appearance
Secures high-stakes glaucoma drug in up to $2.45b bet on eye care pipeline
New annual observance aims to promote safe sun exposure, screening, and preventive healthcare as nearly 77% of Indians are estimated to be Vitamin D deficient
Highlights India’s advances in pharmacopoeial science, regulatory standards, and global harmonization efforts at the 16th International Meeting of World Pharmacopoeias
Mahler brings more than 20 years of leadership experience spanning cell therapy, biopharmaceutical development, manufacturing, and global business management
Partnership enters its ninth year after training over 2,200 young people and enabling employment for more than 1,750 beneficiaries through nursing assistant and digital skills programs
Report reveals growing confidence in AI-driven decision-making, but highlights persistent challenges in scaling digital investments and converting innovation into measurable business value
Founded by serial entrepreneur Dinakara Nagalla, the platform enters the Indian market with 30,000 users, and 500 wellbeing professionals
Market grows 12.1%; volume contribution improves as 9 out of 10 key therapies post double-digit growth
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
